The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor-1 Ligands

被引:44
作者
Anisimov, Andrey [1 ,2 ]
Leppanen, Veli-Matti [3 ]
Tvorogov, Denis [1 ,2 ]
Zarkada, Georgia [1 ,2 ,3 ]
Jeltsch, Michael [1 ,2 ,3 ]
Holopainen, Tanja [1 ,2 ]
Kaijalainen, Seppo [1 ,2 ]
Alitalo, Kari [1 ,2 ,3 ]
机构
[1] Univ Helsinki, Biomedicum Helsinki, Translat Canc Biol Program, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Univ Helsinki Cent Hosp, FIN-00014 Helsinki, Finland
[3] Biomedicum Helsinki, Wihuri Res Inst, FIN-00290 Helsinki, Finland
基金
芬兰科学院; 欧洲研究理事会;
关键词
IMMUNOGLOBULIN-LIKE DOMAIN; FACTOR VEGF FAMILY; FACTOR-B; SIGNAL-TRANSDUCTION; PATHOLOGICAL ANGIOGENESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING; KINASE; ACTIVATION;
D O I
10.1126/scisignal.2003905
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factors (VEGFs) regulate blood and lymphatic vessel development through VEGF receptors (VEGFRs). The VEGFR immunoglobulin homology domain 2 (D2) is critical for ligand binding, and D3 provides additional interaction sites. VEGF-B and placenta growth factor (PlGF) bind to VEGFR-1 with high affinity, but only PlGF is angiogenic in most tissues. We show that VEGF-B, unlike other VEGFs, did not require D3 interactions for high-affinity binding. VEGF-B with a PlGF-derived L1 loop (B-L1(P)) stimulated VEGFR-1 activity, whereas PlGF with a VEGF-B-derived L1 loop (P-L1(B)) did not. Unlike P-L1(B) and VEGF-B, B-L1(P) and PlGF were also angiogenic in mouse skeletal muscle. Furthermore, B-L1(P) also bound to VEGFR-2 and activated downstream signaling. These results establish a role for L1-mediated D3 interactions in VEGFR activation in endothelial cells and indicate that VEGF-B is a high-affinity VEGFR-1 ligand that, unlike PlGF, cannot efficiently induce signaling downstream of VEGFR-1.
引用
收藏
页数:10
相关论文
共 58 条
  • [1] Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect
    Aase, K
    von Euler, G
    Li, X
    Pontén, A
    Thorén, P
    Cao, R
    Cao, Y
    Olofsson, B
    Gebre-Medhin, S
    Pekny, M
    Alitalo, K
    Betsholtz, C
    Eriksson, U
    [J]. CIRCULATION, 2001, 104 (03) : 358 - 364
  • [2] Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3
    Achen, MG
    Roufail, S
    Domagala, T
    Catimel, B
    Nice, EC
    Geleick, DM
    Murphy, R
    Scott, AM
    Caesar, C
    Makinen, T
    Alitalo, K
    Stacker, SA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (09): : 2505 - 2515
  • [3] Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
    Albrecht, Imke
    Kopfstein, Lucie
    Strittmatter, Karin
    Schomber, Tibor
    Falkevall, Annelie
    Hagberg, Carolina E.
    Lorentz, Pascal
    Jeltsch, Michael
    Alitalo, Kari
    Eriksson, Ulf
    Christofori, Gerhard
    Pietras, Kristian
    [J]. PLOS ONE, 2010, 5 (11):
  • [4] Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
    Anisimov, Andrey
    Alitalo, Annamari
    Korpisalo, Petra
    Soronen, Jarkko
    Kaijalainen, Seppo
    Leppanen, Veli-Matti
    Jeltsch, Michael
    Yla-Herttuala, Seppo
    Alitalo, Kari
    [J]. CIRCULATION RESEARCH, 2009, 104 (11) : 1302 - U156
  • [5] [Anonymous], 2007, CELL, V131, P463
  • [6] Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
    Autiero, M
    Waltenberger, J
    Communi, D
    Kranz, A
    Moons, L
    Lambrechts, D
    Kroll, J
    Plaisance, S
    De Mol, M
    Bono, F
    Kliche, S
    Fellbrich, G
    Ballmer-Hofer, K
    Maglione, D
    Mayr-Beyrle, U
    Dewerchin, M
    Dombrowski, S
    Stanimirovic, D
    Van Hummelen, P
    Dehio, C
    Hicklin, DJ
    Persico, G
    Herbert, JM
    Communi, D
    Shibuya, M
    Collen, D
    Conway, EM
    Carmeliet, P
    [J]. NATURE MEDICINE, 2003, 9 (07) : 936 - 943
  • [7] PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
    Bais, Carlos
    Wu, Xiumin
    Yao, Jenny
    Yang, Suya
    Crawford, Yongping
    McCutcheon, Krista
    Tan, Christine
    Kolumam, Ganesh
    Vernes, Jean-Michel
    Eastham-Anderson, Jeffrey
    Haughney, Peter
    Kowanetz, Marcin
    Hagenbeek, Thijs
    Kasman, Ian
    Reslan, Hani Bou
    Ross, Jed
    Van Bruggen, Nick
    Carano, Richard A. D.
    Meng, Yu-Ju Gloria
    Hongo, Jo-Anne
    Stephan, Jean-Philippe
    Shibuya, Masabumi
    Ferrara, Napoleone
    [J]. CELL, 2010, 141 (01) : 166 - 177
  • [8] Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia
    Bellomo, D
    Headrick, JP
    Silins, GU
    Paterson, CA
    Thomas, PS
    Gartside, M
    Mould, A
    Cahill, MM
    Tonks, ID
    Grimmond, SM
    Townson, S
    Wells, C
    Little, M
    Cummings, MC
    Hayward, NK
    Kay, GF
    [J]. CIRCULATION RESEARCH, 2000, 86 (02) : E29 - E35
  • [9] Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization
    Brozzo, Maurice S.
    Bjelic, Sasa
    Kisko, Kaisa
    Schleier, Thomas
    Leppanen, Veli-Matti
    Alitalo, Kari
    Winkler, Fritz K.
    Ballmer-Hofer, Kurt
    [J]. BLOOD, 2012, 119 (07) : 1781 - 1788
  • [10] Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
    Bry, Maija
    Kivela, Riikka
    Holopainen, Tanja
    Anisimov, Andrey
    Tammela, Tuomas
    Soronen, Jarkko
    Silvola, Johanna
    Saraste, Antti
    Jeltsch, Michael
    Korpisalo, Petra
    Carmeliet, Peter
    Lemstrom, Karl B.
    Shibuya, Masabumi
    Yla-Herttuala, Seppo
    Alhonen, Leena
    Mervaala, Eero
    Andersson, Leif C.
    Knuuti, Juhani
    Alitalo, Kari
    [J]. CIRCULATION, 2010, 122 (17) : 1725 - 1733